Pusey C D, Dash A, Kershaw M J, Morgan A, Reilly A, Rees A J, Lockwood C M
Lab Invest. 1987 Jan;56(1):23-31.
A mouse monoclonal antibody (P1) to the autoantigenic component of human glomerular basement membrane (GBM) was used to study the immunochemistry and tissue distribution of the Goodpasture antigen and the specificity of the human autoimmune response in Goodpasture's syndrome (anti-GBM disease). In solid phase assays, monoclonal antibody P1 bound to collagenase-solubilized human GBM (the ligand used in assays for human autoantibody), but not to other biochemically defined components of basement membrane. On Western blotting, P1 bound to the same 6 bands in solubilized GBM (between 26 and 58 kilodaltons with major bands at 26 and 54 kilodaltons) that were recognized by sera from all 42 patients studied with anti-GBM disease. Preincubation with sera from 8/8 patients blocked the subsequent binding of P1 from 83 to 89% on densitometer scanning of the Western blot; and preincubation with P1 blocked the binding of sera from 6/6 patients from 58 to 89%. Indirect immunofluorescence and immunoperoxidase studies revealed that the pattern of binding of P1 was identical to that of antibody eluted from the kidneys of a patient with Goodpasture's syndrome; there was linear binding to GBM, Bowman's capsule, and distal tubular basement membrane. In addition, P1 bound to basement membranes in lung and choroid plexus, and to membranes of the lens capsule, choroid, and retina of the eye and cochlea, but not to other organs studied. It is concluded that there is a single major autoantigenic component of human GBM (the Goodpasture antigen), which is present on fragments of different molecular weight in the collagenase digest. This antigen is distributed throughout well-defined basement membranes known to be involved in both Goodpasture's and Alport's syndromes. Human anti-GBM antibodies bind to the same (or closely related) determinants which are recognized by P1, demonstrating that the autoimmune response in Goodpasture's syndrome is of highly restricted specificity.
一种针对人肾小球基底膜(GBM)自身抗原成分的小鼠单克隆抗体(P1)被用于研究Goodpasture抗原的免疫化学和组织分布,以及Goodpasture综合征(抗GBM病)中人类自身免疫反应的特异性。在固相分析中,单克隆抗体P1与胶原酶溶解的人GBM(用于检测人自身抗体的配体)结合,但不与基底膜的其他生化定义成分结合。在蛋白质印迹法中,P1与溶解的GBM中相同的6条带(分子量在26至58千道尔顿之间,主要条带在26和54千道尔顿)结合,这些条带可被研究的42例抗GBM病患者的血清识别。用8/8例患者的血清预孵育后,在蛋白质印迹法的密度计扫描中,P1随后的结合被阻断83%至89%;用P1预孵育可使6/6例患者的血清结合被阻断58%至89%。间接免疫荧光和免疫过氧化物酶研究表明,P1的结合模式与从一名Goodpasture综合征患者肾脏洗脱的抗体相同;与GBM、鲍曼囊和远端肾小管基底膜呈线性结合。此外,P1与肺和脉络丛的基底膜、眼晶状体囊膜、脉络膜和视网膜以及耳蜗的膜结合,但不与研究的其他器官结合。结论是人GBM存在单一主要自身抗原成分(Goodpasture抗原),其在胶原酶消化产物中以不同分子量片段存在。该抗原分布于已知与Goodpasture综合征和Alport综合征相关的明确基底膜中。人抗GBM抗体与P1识别的相同(或密切相关)决定簇结合,表明Goodpasture综合征中的自身免疫反应具有高度受限的特异性。